---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-002440"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2023-04-20T23:59:59+00:00"
generated_at: "2026-06-16T22:26:40.066823+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology to effect 1-for-20 reverse stock split on April 24 for Nasdaq compliance

## Summary
- 1-for-20 reverse stock split effective 12:01 a.m. April 24, 2023; trading begins split-adjusted same day.
- Split reduces outstanding shares from 79.6M to approximately 3.98M, with fractional shares rounded up.
- Purpose is to regain compliance with Nasdaq minimum bid price requirement for continued listing.
- Shareholders approved split at a reconvened special meeting on April 19, 2023; ratio determined by Board.
- CUSIP changes to 74039M309; par value remains $0.01 per share; symbol unchanged (POAI).

## SEC filing metadata
- accession: 0001171843-23-002440
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2023-04-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184323002440/0001171843-23-002440-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184323002440/f8k_042023.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-002440
- JSON: https://secwatch.observer/filing/0001171843-23-002440.json
- Plain text: https://secwatch.observer/filing/0001171843-23-002440.txt

## Key facts
- Governance Changes
  Axe Compute Inc.: Amended certificate of incorporation to effect a 1-for-20 reverse stock split of common stock (effective 2023-04-24).
  - Change: charter amendment
  - Effective: 2023-04-24
  source text: On April 19, 2023, Predictive Oncology Inc. (the “Company”) filed a Certificate of Amendment to the Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect a 1-for-20 reverse stock split of the shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), effective as of 12:01 a.m. (Delaware time) on April 24, 2023 (the “Reverse Stock Split”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184323002440/0001171843-23-002440-index.htm
- Shareholder Votes
  Axe Compute Inc. shareholders approved To approve an amendment of the Company’s certificate of incorporation to effect a reverse stock split of the outstanding shares of its common stock at a ratio of not less than one-for-two (1:2) and not more than one-for-twenty-five (1:25), with the exact ratio to be set at a whole number within this at the 2023-04-19 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-04-19
  source text: 1. To approve an amendment of the Company’s certificate of incorporation to effect a reverse stock split of the outstanding shares of its common stock at a ratio of not less than one-for-two (1:2) and not more than one-for-twenty-five (1:25), with the exact ratio to be set at a whole number within this range as determined by our Board of Directors (the “Reverse Split Proposal”). For Against Abstain Broker Non-Votes 29,332,407,453 6,785,775,332 548,565,438 5,000,001
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184323002440/0001171843-23-002440-index.htm
- Shareholder Votes
  Axe Compute Inc. shareholders approved To approve a proposal to adjourn the Special Meeting, if necessary, to solicit additional proxies for approval of the Reverse Split Proposal, in the event that there are not sufficient votes at the time of the Special Meeting to approve such proposal at the 2023-04-19 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-04-19
  source text: 2. To approve a proposal to adjourn the Special Meeting, if necessary, to solicit additional proxies for approval of the Reverse Split Proposal, in the event that there are not sufficient votes at the time of the Special Meeting to approve such proposal (the “Adjournment Proposal”). For Against Abstain Broker Non-Votes 23,828,229,377 7,327,325,751 868,886,698 4,647,603,397
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184323002440/0001171843-23-002440-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.